Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Zhidong Hu, Jingxian Xia, Juan Wu, Huimin Zhao, Ping Ji, Ling Gu, Wenfei Gu, Zhenyan Chen, Jinchuan Xu, Xuejiao Huang, Jian Ma, Anke Chen, Jixi Li, Tsugumine Shu & Xiao-Yong Fan. (2024) A multistage Sendai virus vaccine incorporating latency-associated antigens induces protection against acute and latent tuberculosis. Emerging Microbes & Infections 13:1.
Read now
Read now
Articles from other publishers (16)
Xanthippi Topalidou, Alexis M. Kalergis & Georgios Papazisis. (2023) Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines. Pathogens 12:10, pages 1259.
Crossref
Crossref
Gleb A. Kudrov, Sergei S. Zainutdinov, Antonina A. Grazhdantseva, Andrey V. Shipovalov, Galina F. Sivolobova, Anastasiya V. Semenova, Iuliia A. Merkuleva, Dmitry N. Shcherbakov, Oleg S. Taranov, Anna V. Zaykovskaya, Irina S. Shulgina, Oleg V. Pyankov & Galina V. Kochneva. (2023) Intranasal vaccine against COVID-19 based on a recombinant variant of the Sendai virus (Paramyxoviridae: <i>Respirovirus</i>) strain Moscow. Problems of Virology 68:3, pages 215-227.
Crossref
Crossref
Congwu Chi & Kunhua Song. (2023) Cellular reprogramming of fibroblasts in heart regeneration. Journal of Molecular and Cellular Cardiology 180, pages 84-93.
Crossref
Crossref
Ching-Yee Loo, Wing-Hin Lee & Qi Tony Zhou. (2023) Recent Advances in Inhaled Nanoformulations of Vaccines and Therapeutics Targeting Respiratory Viral Infections. Pharmaceutical Research 40:5, pages 1015-1036.
Crossref
Crossref
Marcelo Comerlato Scotta & Renato Tetelbom Stein. (2023) Current strategies and perspectives for active and passive immunization against Respiratory Syncytial Virus in childhood. Jornal de Pediatria 99, pages S4-S11.
Crossref
Crossref
Satoru Morimoto, Koichi Saeki, Masaru Takeshita, Kunio Hirano, Mariko Shirakawa, Yumiko Yamada, Shiho Nakamura, Fumiko Ozawa & Hideyuki Okano. (2022)
Intranasal Sendai virus‐based
SARS‐CoV
‐2 vaccine using a mouse model
. Genes to Cells 28:1, pages 29-41.
Crossref
Crossref
Natalie I Mazur, Jonne Terstappen, Ranju Baral, Azucena Bardají, Philippe Beutels, Ursula J Buchholz, Cheryl Cohen, James E CroweJrJr, Clare L Cutland, Linda Eckert, Daniel Feikin, Tiffany Fitzpatrick, Youyi Fong, Barney S Graham, Terho Heikkinen, Deborah Higgins, Siddhivinayak Hirve, Keith P Klugman, Leyla Kragten-Tabatabaie, Philippe Lemey, Romina Libster, Yvette Löwensteyn, Asuncion Mejias, Flor M Munoz, Patrick K Munywoki, Lawrence Mwananyanda, Harish Nair, Marta C Nunes, Octavio Ramilo, Peter Richmond, Tracy J Ruckwardt, Charles Sande, Padmini Srikantiah, Naveen Thacker, Kody A Waldstein, Dan Weinberger, Joanne Wildenbeest, Dexter Wiseman, Heather J Zar, Maria Zambon & Louis Bont. (2023) Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape. The Lancet Infectious Diseases 23:1, pages e2-e21.
Crossref
Crossref
Ruth A. Karron. 2023. Plotkin's Vaccines. Plotkin's Vaccines
998
1004.e5
.
Camila Montesinos-Guevara, Diana Buitrago-Garcia, Maria L Felix, Claudia V Guerra, Ricardo Hidalgo, Maria José Martinez-Zapata & Daniel Simancas-Racines. (2022) Vaccines for the common cold. Cochrane Database of Systematic Reviews 2022:12.
Crossref
Crossref
Zhuang Teng, Ling-Yang Meng, Jian-Ke Yang, Zheng He, Xi-Guang Chen & Ya Liu. (2022) Bridging nanoplatform and vaccine delivery, a landscape of strategy to enhance nasal immunity. Journal of Controlled Release 351, pages 456-475.
Crossref
Crossref
Fengling Feng, Ziyu Wen, Jiaoshan Chen, Yue Yuan, Congcong Wang & Caijun Sun. (2022) Strategies to Develop a Mucosa-Targeting Vaccine against Emerging Infectious Diseases. Viruses 14:3, pages 520.
Crossref
Crossref
S. S. Zainutdinov, G. F. Sivolobova, V. B. Loktev & G. V. Kochneva. (2022) Mucosal immunity and vaccines against viral infections. Problems of Virology 66:6, pages 399-408.
Crossref
Crossref
Bin Zheng, Wenchang Peng, Lin Gan, Mingming Guo, Shuchao Wang, Xiao-Dong Zhang & Dong Ming. (2021) Sendai virus-based immunoadjuvant in hydrogel vaccine intensity-modulated dendritic cells activation for suppressing tumorigenesis. Bioactive Materials 6:11, pages 3879-3891.
Crossref
Crossref
Hai Li, Hu Ren, Yan Zhang, Lei Cao & Wenbo Xu. (2021) Intranasal vaccination with a recombinant protein CTA1-DD-RBF protects mice against hRSV infection. Scientific Reports 11:1.
Crossref
Crossref
Charles J. Russell & Julia L. Hurwitz. (2021) Sendai Virus-Vectored Vaccines That Express Envelope Glycoproteins of Respiratory Viruses. Viruses 13:6, pages 1023.
Crossref
Crossref
Rhiannon R. Penkert, Nehali Patel, Richard J. Webby, Ted M. Ross & Julia L. Hurwitz. (2021) Month of Influenza Virus Vaccination Influences Antibody Responses in Children and Adults. Vaccines 9:2, pages 68.
Crossref
Crossref